Lipopolysaccharide and the gut microbiota: considering structural variation

AE Mohr, M Crawford, P Jasbi, S Fessler… - FEBS …, 2022 - Wiley Online Library
Systemic inflammation is associated with chronic disease and is purported to be a main
pathogenic mechanism underlying metabolic conditions. Microbes harbored in the host …

Lipopolysaccharide and the gut microbiota: considering structural variation

AE Mohr, P Jasbi, S Fessler, KL Sweazea - FEBS Letters, 2022 - asu.elsevierpure.com
Systemic inflammation is associated with chronic disease and is purported to be a main
pathogenic mechanism underlying metabolic conditions. Microbes harbored in the host …

Lipopolysaccharide and the gut microbiota: considering structural variation.

AE Mohr, M Crawford, P Jasbi, S Fessler… - FEBS …, 2022 - europepmc.org
Systemic inflammation is associated with chronic disease and is purported to be a main
pathogenic mechanism underlying metabolic conditions. Microbes harbored in the host …

Lipopolysaccharide and the gut microbiota: considering structural variation

AE Mohr, P Jasbi, S Fessler, KL Sweazea - FEBS letters, 2022 - pubmed.ncbi.nlm.nih.gov
Systemic inflammation is associated with chronic disease and is purported to be a main
pathogenic mechanism underlying metabolic conditions. Microbes harbored in the host …